Culture

Curbing COVID-19 on campuses nationwide

While COVID-19 cases may be on the decline, the virus is still prevalent nationwide, and higher education institutions need to prepare for a successful 2021 academic year. New research from Clemson University in The Lancet Child & Adolescent Health, one of the world's premier peer-reviewed general medical journals, indicates how surveillance-based informative testing (SBIT) mitigates the spread of COVID-19 on campus, paving the way for other institutions, even those without the infrastructure or funding for mass-scale testing.

SBIT was implemented during the first two weeks of the Fall semester at Clemson. According to the study, random surveillance testing to identify outbreaks in residence halls and with targeted follow-up testing was twice as likely to detect a positive case than random testing models. In the absence of SBIT, transmission models developed by the research team show COVID cases would have increased by 154 percent.

"By focusing on residential hotspots, our SBIT strategy identified and contained outbreaks throughout campus. This strategy made efficient use of our resources, detecting positive cases at twice the rate of simple random testing," said Lior Rennert, assistant professor with the College of Behavioral, Social and Health Sciences.

The study is the first to document the implementation, results and relative effectiveness in detecting and containing COVID-19 outbreaks and mitigating university campuses' spread. For most universities, voluntary testing was implemented, leaving many cases undetected and contributing to an increase of COVID on campuses and in their surrounding communities.

The surveillance-based informative testing was spearheaded by Clemson's public health team. The authors of the manuscript are Lior Rennert, Christopher McMahan, Corey Kalbaugh, Yuan Yang, Brandon Lumsden, Delphine Dean, Lesslie Pekarek and Christopher Colenda, and are the first Clemson team to publish in a Lancet family journal.

Clemson's commitment to COVID-19 safety

The study's research team played an integral role in the University's ability to bring students back to campus in Fall 2020. Towards the tail end of the semester, there was a precipitous decline in student cases, despite significant increases in the case counts in surrounding communities. The declines were due in large part to the public health strategies implemented. At the pinnacle of these strategies was an aggressive plan to test as many students and employees as often as possible. By identifying active cases, the University was able to mitigate the virus's community spread, thus reducing risk to students, faculty, and the larger community.

What Clemson faced was not unique - and it was not the only campus with a high number of reported cases. The difference? Clemson implemented a robust and repetitive testing strategy for students and faculty regardless of symptoms or exposure. In doing so, positive cases were identified and removed from the population, thus limiting the virus's spread both on-campus and in surrounding communities through isolation and quarantine procedures.

Clemson's public health strategies were derived through data-driven means. Over the summer, the University's public health team designed and built models demonstrating pre-semester testing would reduce the spread and minimize peak cases during the semester. Acting on these findings, the University mandated all students and faculty be tested before returning to face-to-face instruction. As a part of these efforts, nearly 3,000 COVID-19 cases were discovered, preventing the return of nearly 3,000 infected students and faculty, who would have unknowingly spread the virus to others - infectivity is thought to be two to four people per confirmed case.

As in-person instruction began, the University also began randomly testing 5 percent of the student body weekly. These surveillance efforts allowed for the identification of "hotspots" in both the on- and off-campus student body. Testing was then redirected to these hotspots. This combination of testing drove the COVID prevalence to below 1 percent.

Since the initial testing efforts, Clemson's positive rate dropped weekly - as did the population using isolation and quarantine accommodations. While most of the credit should rightfully lie with students' responsible behavior, the University's public health strategies undoubtedly contributed to the decreasing case count. Beginning October 2020, the public health team implemented a weekly testing regime, keeping disease prevalence down ever since.

Credit: 
Clemson University

Food industry lobbying was intense on failed bill to limit marketing to Canadian children

image: Doctoral student Christine Mulligan

Image: 
Christine Mulligan, courtesy of Nutritional Sciences, University of Toronto

Researchers at the University of Toronto have found that food industry interactions with government heavily outnumbered non-industry interactions on Bill S-228, also known as the Child Health Protection Act, which died in the Senate of Canada in 2019.

The researchers looked at more than 3,800 interactions, which included meetings, correspondence and lobbying, in the three years before the bill failed. They found that over 80 per cent were by industry, compared to public health or not-for-profit organizations.

They also found that industry accounted for over 80 per cent of interactions with the highest-ranking government offices, including elected parliamentarians and their staff and unelected civil servants.

"Industry interacted with government much more often, more broadly, and with higher ranking offices than non-industry representatives in discussions of children's marketing and Bill S-228," said principal investigator Mary L'Abbé, a professor of nutritional sciences at U of T and a researcher in the Joannah & Brian Lawson Centre for Child Nutrition.

The journal CMAJ Open published the study today.

The researchers drew data from Health Canada's Meetings and Correspondence on Healthy Eating database, set up in 2016, which details the type and content of interactions between stakeholders and Health Canada on nutrition policies. They also used Canada's Registry of Lobbyists, which tracks the names and registrations of paid lobbyists but provides limited details on the content of the meetings.

"We're fortunate to have access to this information in Canada, as it offers insight into the story of government bills," said Christine Mulligan, a doctoral student in L'Abbé's lab and lead author on the study. "Industry stakeholders bring important viewpoints, but the volume and breadth of their lobbying on this bill was clearly disproportionate, especially compared to public health."

The food industry has a long history of effective lobbying in Canada and other countries, and a growing body of research has documented both that extensive influence and the need for policy makers to be aware of it when creating policy that promotes the health and safety of all citizens.

Health Canada met with industry 56 per cent of the time regarding the 2016 Healthy Eating Strategy, researchers at the University of Ottawa found earlier this year. And during creation of the recent Food Guide, Health Canada restricted industry lobbying -- so effectively that industry persuaded officials at Agriculture and Agri-Food Canada to lobby Health Canada on their behalf, as The Globe and Mail and other organizations reported.

Mulligan says the disparity in interactions with government among stakeholders was even greater for S-228, and that it marks a stark contrast between this bill and interactions on the Healthy Eating Strategy more broadly.

Industry lobbying has also been prominent on a stalled bill to introduce front-of-package labelling that would inform consumers about foods high in salt, sugar and saturated fat, said L'Abbé, who advised Health Canada on both bills and the Healthy Eating Strategy.

L'Abbé said that more transparency on interactions with Agriculture and Agri-Food Canada and other federal departments would help, as would more detail in the Registry of Lobbyists. All stakeholder comments related to proposed regulations are part of a public docket in the U.S., and some groups have called for a similar approach in Canada.

"We desperately need better management of the consultative process on legislative bills, for public health policy in the public good," said L'Abbé.

Credit: 
University of Toronto

USPSTF statement on screening for hearing loss in older adults

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) concludes that current evidence is insufficient to make a recommendation about screening for hearing loss in asymptomatic adults 50 and older. Nearly 16% of U.S. adults 18 and over report difficulty hearing. Hearing loss has been associated with an increased risk of falls, hospitalizations, social isolation and cognitive decline. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this recommendation is similar to its 2012 statement.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2021.2566)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

Credit: 
JAMA Network

Microchip models of human lungs enable better understanding of disease, immune response

image: Simplified schematic model of the human lung with healthy and virus-infected alveolar sacs along with a viral infection on a lung alveolus platform.

Image: 
Yildiz-Ozturk

WASHINGTON, March 23, 2021 -- According to the National Institutes of Health, respiratory viruses are the most frequent cause of disease and death in humans, a fact highlighted by the COVID-19 pandemic. Despite the potential to cause severe disease, over 70% of viral infections remain asymptomatic.

Animal models have been used widely to understand how these viruses infect the host and how the host responds to prevent infection and onset of diseases. Data based on animal models, however, does not always apply well to humans, given the variability in species and genetics.

In Biomicrofluidics, by AIP Publishing, researchers from Ege University and the University of Nottingham review a range of lung-on-chip technologies that represent the vital properties of lung tissue and are capable of recapitulating the fundamental aspects of various pathologies.

"Lung-on-chip platforms are able to reconstruct the multicellular architecture, the physiochemical microenvironment, and the tissue-tissue interface of the human lung in vitro," said author Ozlem Yesil-Celiktas.

The researchers reviewed various state-of-the-art lung-on-chips and their applications in examining, diagnosing, and treating human viruses, including the coronavirus that causes COVID-19. Different platforms focus on different parts of the lung functions, such as small airway-on-chips and lung alveolus chips.

The knowledge and expertise accumulated through the development of physiologically relevant lung-on-chip models paves the way to use these models to study the interaction of several human respiratory viruses with the airway epithelium and alveolus in an organ-relevant setting.

"The current pandemic, which spread to almost every continent in just a few months, makes us realize how much we need a practical, humanized platform to expedite the trials for potential antiviral drugs and vaccines," said Yesil-Celiktas.

Considering new research showing one of the aftereffects of COVID-19-related pneumonia is pulmonary fibrosis, the lung-on-chip systems, which focus on lung fibrosis, enable a deeper understanding of disease mechanisms and related immune and technological responses.

Despite the advantages, the lack of vascularity and integration with external immune cells means these organ-chip platforms require the integration of these components to the microchips, not only for viral infections but also for other pathologies.

Going forward, the researchers will integrate modular sensing apparatus to provide online monitoring opportunities along with diagnostic outcomes. Such biomimetic systems also enable high-resolution and real-time imaging, as well as in vitro toxicological analysis or measurements of metabolic activities of living cells.

Credit: 
American Institute of Physics

In-person, telehealth care, costs before, during COVID-19 pandemic

What The Study Did: This study of working-age people enrolled in private health plans from March 2019 through June 2020 documented patterns of care at the onset of COVID-19.

Authors: Jonathan P. Weiner, Dr.P.H., Johns Hopkins Bloomberg School of Public Health in Baltimore, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2021.2618)

Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Representation of Black Americans in clinical trials of cardiovascular drugs

What The Study Did: Researchers investigated representation of Black Americans in clinical trials of cardiovascular drugs approved by the U.S. Food and Drug Administration between 2006 and 2020.

Authors: Jiarui Li, M.D., of the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, China, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2021.2640)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Dementia death risk is higher among the socioeconomically deprived

A large proportion of dementia deaths in England and Wales may be due to socioeconomic deprivation, according to new research led by Queen Mary University of London.

The team also found that socioeconomic deprivation was associated with younger age at death with dementia, and poorer access to accurate diagnosis.

Dementia is the leading cause of death in England and Wales, even during the COVID pandemic, and is the only disease in the top ten causes of death without effective treatment.

The research, published in the Journal of Alzheimer's Disease, examines Office for National Statistics mortality data for England and Wales, and finds that in 2017, 14,837 excess dementia deaths were attributable to deprivation, equating to 21.5 per cent of all dementia deaths that year. The team also found that the effect of this association appears to be increasing over time.

Corresponding author Dr Charles Marshall from Queen Mary University of London, whose work is funded by Barts Charity, said: "Understanding how we might prevent dementia deaths is especially important. Persistent and widening socioeconomic inequality might be having an unrecognised impact on brain health. Addressing this inequality could be an important strategy to help stem the rising tide of dementia."

Various factors have been hypothesised to mediate the relationship between dementia and socioeconomic deprivation, including education, diet, vascular risk factors, stress and access to healthcare.

It is likely that poorer quality of diagnosis in more deprived patients means that they are being disadvantaged in terms of prognosis, counselling, planning of future care, access to appropriate symptomatic treatments and opportunities to participate in research.

The researchers say that although a direct causal relationship between socioeconomic status and dementia has yet to be established, deprivation could be a major target in public health approaches aimed at reducing the population burden of dementia.

The study has limitations in that it is an observational study, meaning that a causal link between deprivation and dementia cannot be confirmed, and there is a lack of detail on specific dementia subtypes within the ONS data which is likely to lead to incomplete ascertainment of dementia cases.

Credit: 
Queen Mary University of London

Babies prefer baby talk, whether they're learning one language or two

It can be hard to resist lapsing into an exaggerated, singsong tone when you talk to a cute baby. And that's with good reason. Babies will pay more attention to baby talk than regular speech, regardless of which languages they're used to hearing, according to a study by UCLA's Language Acquisition Lab and 16 other labs around the globe.

The study found that babies who were exposed to two languages had a greater interest in infant-directed speech -- that is, an adult speaking baby talk -- than adult-directed speech. Research has already shown that monolingual babies prefer baby talk.

Some parents worry that teaching two languages could mean an infant won't learn to speak on time, but the new study shows bilingual babies are developmentally right on track. The peer-reviewed study, published today by Advances in Methods and Practices in Psychological Science, found bilingual babies became interested in baby talk at the same age as those learning one language.

"Crucially for parents, we found that development of learning and attention is similar in infants, whether they're learning one or two languages," said Megha Sundara, a UCLA linguistics professor and director of the Language Acquisition Lab. "And, of course, learning a language earlier helps you learn it better, so bilingualism is a win-win."

In the study, which took place at 17 labs on four continents, researchers observed 333 bilingual babies and 384 monolingual babies, ranging in age from 6 to 9 months and 12 to 15 months. UCLA's lab was the only one to provide data on bilingual babies who grew up hearing both English and Spanish. Sundara and Victoria Mateu, a UCLA assistant professor of Spanish and Portuguese, observed babies who were 12 to 15 months old.

Each baby would sit on a parent's lap while recordings of an English-speaking mother, using either infant-directed speech or adult-directed speech, played from speakers on the left or the right. Computer tracking measured how long each baby looked in the direction of each sound.

"The longer they looked, the stronger their preference," Mateu said. "Babies tend to pay more attention to the exaggerated sounds of infant-directed speech."

Infants' interest in English baby talk was very fine-tuned, the study noted. Bilingual parents indicated the percent of time English was spoken at home compared to Spanish. The more English the bilingual babies had been exposed to, the stronger their preference for infant-directed speech compared to adult-directed speech. However, even babies with no exposure to English preferred the English baby talk to the grown-up talk, Mateu said.

Baby talk is found across most languages and cultures, but English has one of the most exaggerated forms, Sundara said.

"Baby talk has a slower rate of speech across all languages, with more variable pitch, and it's more animated and happy," she said. "It varies mainly in how exaggerated it is."

Led by Krista Byers-Heinlein, a psychology professor at Concordia University in Montreal, the study involved labs in the United States, Canada, Europe, Australia and Singapore. The study's global reach strengthened the results, Sundara said.

"When you do language research, you want to know that the results aren't just some quirk of the language you're studying," she said.

According to the study, 6- to 9-month-old babies who had mothers with higher levels of education preferred baby talk more than babies whose mothers had less education.

"We suspect that perhaps the mothers with higher education levels spoke more to the babies and used infant-directed speech more often," Mateu said.

This study is one of the first published by the ManyBabies Consortium, a multi-lab group of researchers. Byers-Heinlein believes the unusual international, multilingual collaboration creates a model for future studies that include a similar breadth of languages and cultures.

"We can really make progress in understanding bilingualism, and especially the variability of bilingualism, thanks to our access to all these different communities," she said.

As the research continues, parents can babble to their babies in one language or two, and rest easy knowing they won't cause any confusion.

Credit: 
University of California - Los Angeles

Parkinson's gene may impair how new neurons are made throughout our lifetime

image: Old (green) and newly made (orange) dopamine-producing nerve cells in the zebrafish brain

Image: 
University of Sheffield

A pioneering study, published in Scientific Reports, found that the Parkinon's gene PINK1 is important for the generation of dopamine-producing neurons throughout life, and is not just responsible for the premature death of these neurons
The international research, led by University of Sheffield's Neuroscience Institute, used two model systems to examine how neurons are produced throughout our lifetime
Parkinson's disease is a relentlessly progressive neurodegenerative disorder that affects around 145,000 people in the UK
A gene defect linked to Parkinson's disease may not only cause the early death of neurons, but also impair the process that generates neurons in the brain throughout our lifetime, a new study has revealed.

The international study, led by the University of Sheffield's Neuroscience Institute, may have a significant impact on the future treatment of Parkinson's patients who develop the illness due to PINK1 defect or similar gene defects.

The development of novel treatments and therapies to slow down disease progression, halt or reverse Parkinson's may now focus on enhancing the generation of new dopamine-producing neurons, rather than just trying to protect these neurons from dying later.

The findings, published today (23 March 2021) in Scientific Reports, used two model systems to measure how inactivation of the PINK1 gene affects dopamine-producing neurons in the adult brain.

Dopamine-producing neurons are the most severely affected brain cells in Parkinson's disease. It is typically thought that Parkinson's genes, such as PINK1, cause early death of these neurons, with symptoms developing when neuron numbers fall. However, here, researchers found that a deficiency in PINK1 resulted in fewer dopamine-producing neurons being made throughout life.

Professor Oliver Bandmann, Professor of Movement Disorders Neurology at the Sheffield Institute for Translational Neuroscience (SITraN), said: "Neurogenesis is the process by which new neurons are formed in the brain. Recent evidence suggests that this process is ongoing throughout life but the relevance of this is poorly understood in neurodegenerative disorders such as Parkinson's disease."

"We know that mutations in the PINK1 gene cause an early onset, inherited form of Parkinson's disease. If we can further our understanding about the impact of this genetic mutation on the dopamine-producing neurons we can develop new therapeutic approaches that aim to mitigate those effects."

In collaboration with the University of Luxembourg, researchers used two complementary model systems to examine how neurons are reproduced throughout our lifetime.

Professor Marysia Placzek, Professor of Developmental Neurobiology in the Department of Biomedical Science, said: "This study attests to the power of using simple model organisms for pre-clinical translational research. We used the zebrafish to demonstrate that dopamine-producing neurons are generated into adulthood at a rate that decreases with age and that PINK1-deficiency impairs neurogenesis of these neurons, significantly in early adult life. Our international collaborators then confirmed these results in a human organoid cell model."

The observation of impaired adult dopaminergic neurogenesis in PINK1 deficiency in two complementing model systems may have significant consequences for future therapeutic approaches in Parkinson's disease. Future research will aim to identify the precise mechanisms that link Parkinson's genes to neurogenesis. This will allow us to explore the development of gene therapy or small molecule approaches to enhance neurogenesis in the brain of patients with Parkinson's. The development of new therapies for brain diseases like Parkinson's is the main focus of the Sheffield Institute for Translational Neuroscience (SITraN).

The research was funded by the Medical Research Council (MRC), Parkinson's UK and the Wellcome Trust.

Parkinson's disease is the second most common neurodegenerative disease, with approximately 10 million people affected worldwide. Currently, only symptomatic treatment options are available to patients.

The University of Sheffield launched a sustained fundraising effort for Parkinson's disease research at the end of 2019. Since then, Sheffield staff, students, alumni and the general public have come together to raise more than £350,000 so far. The ongoing efforts of this campaign are set to continue as Sheffield dedicates itself to backing the next breakthrough.

Credit: 
University of Sheffield

These baby great white sharks love to hang out near New York

image: A young white shark is tagged using satellite technology, which tracked their 3D movements in the New York Bight between 2016 and 2019.

Image: 
OCEARCH/R. Snow

Uncovering detailed travel patterns and habitat use of sharks along and across shelf territories has been historically challenging - especially for most pelagic shark species - which remain offshore for most of their lives. Their vertical diving behavior has been a subject of inquiry for a long time, and for young sharks in particular, has remained elusive.

Using cutting-edge 3D satellite technology, a study led by Florida Atlantic University's Harbor Branch Oceanographic Institute, in collaboration with NOAA's National Marine Fisheries Service; OCEARCH; The South Fork Natural History Museum and Nature Center; and the Wildlife Conservation Society, is providing a unique look into how young white sharks in the North Atlantic Ocean travel and use their habitats. The study also is the first to provide fine-scale analysis of vertical movement behavior in young-of-year (1 to 2 years) and juvenile white sharks (Carcharodon carcharias) in the New York Bight, the only confirmed white shark nursery area in the entire North Atlantic Ocean.

Results published in the journal Frontiers in Marine Science, showed that across multiple years, the tagged young white sharks consistently displayed horizontal movements parallel to Long Island's southern shoreline and the New Jersey coast and likely cling to these waters due to their summertime productivity. Horizontal movements ranged from the surf zone to more than 130 kilometers from shore; however, more than 90 percent of the sharks were positioned within 20 kilometers of Long Island's southern shoreline, which further confirms the importance of this region to baby white sharks.

Data from the study simultaneously address many questions on the ecology, behavior and conservation of a highly mobile marine species that has been challenging to explore, and will inform ongoing preservation strategies for this vulnerable white shark population.

"We have known about the importance of nurseries for young sharks for some time, however, knowledge of the finer scale use of shelf systems by these animals has been limited. This lack of information impacts our understanding of potential shark 'hotspots' within these large ecosystems," said Rachel Shaw, lead author, and a recent graduate from the Fisheries Ecology and Conservation (FEC) Lab, led by Matt Ajemian, Ph.D., co-author and an assistant research professor at FAU Harbor Branch.

Between 2016 and 2019, 21 young-of-year and juvenile white sharks were fitted with satellite and acoustic tags to examine their distribution and habitat selection during late summertime (August to October) in the New York Bight - the coastal region between Montauk, New York and Cape May, New Jersey. Movement data from the 21 young white sharks were collected (11 males and 10 females ranging in size from 54 to 61 inches in length) and linked to environmental measurements from remote sensing platforms.

These data sets produced the first-ever glimpse into the 3D movements for these young white sharks alongside oceanographic features like bathymetry (submarine topography), sea surface temperature, chlorophyll-a levels, and sea surface salinity.

"Undoubtedly, our research shows that young white sharks traverse variable oceanographic features across the continental shelf in the New York Bight, but they certainly have their habitat preferences," said Shaw.

The vertical diving behavior and accompanying measurements showed that sharks encountered several areas across the shelf with thermally stratified water column structure. This was most evident around the Hudson Shelf Valley region where some of the coldest bottom temperatures were recorded during the summertime, and is indicative of the "cold pool" that sets up in this region. Further, young white sharks also selected areas with relatively high levels of productivity (i.e., mesotrophic waters) as reflected by salinity and chlorophyll-a concentration. Tagged individuals selected sea surface salinities slightly less saline than oceanic waters, which are typically associated with coastal areas.

Altogether, the research suggests young white sharks prefer nearshore habitats, but can exhibit connectivity between the immediate shoreline and mid-continental shelf region, where they play important ecological roles as apex predators on a variety of species. The study improves characterization of essential habitat for young white sharks and provides new insights into their reliance on this productive continental shelf ecosystem, which may provide them with the resources needed to grow quickly as well as a refuge from predators.

"While the northwest Atlantic white shark population appears to be recovering from historical overfishing, there is considerable uncertainty in their population dynamics, seasonal habitat preferences, ecological roles, and exposure to environmental impacts," said Ajemian. "Understanding species-habitat relationships is critical for predicting the potential impacts of long-term environmental changes including climate change, which is disproportionately affecting this region."

Credit: 
Florida Atlantic University

Extroverts and introverts showed differences in mood during early COVID 19 pandemic

image: Phone-based app used in study

Image: 
Dr. Jim Hudziak

More extroverted people suffered mood declines while more introverted people saw mood improvements during the early COVID-19 pandemic, in survey of students at a U.S. university.

Credit: 
PLOS

The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia

In Slovakia, in counties subject to two rounds of rapid antigen testing for SARS-CoV-2 where those who tested positive then isolated, the approach helped decrease the prevalence of positive tests by more than 50% in a week - all while primary schools and workplaces remained open. "While it was impossible to disentangle the precise contribution of control measures and mass testing," the authors said, mass testing is likely to have had a substantial effect, their modeling showed. Applying mass testing may provide a valuable tool in future containment of SARS-CoV-2 elsewhere, they say. Compared to mandating closure of schools and non-essential businesses, which has had an unprecedented economic effect worldwide during the COVID pandemic, mass testing campaigns for SARS-CoV-2 - which can be conducted while such places remain open - are an alternative way to identify and target infectious individuals without much added burden to those who are not infectious. In October and November 2020, to identify cases at scale and rapidly reduce transmission, in order to ease the conditions of lockdown, Slovakia used rapid antigen tests in a campaign targeting the whole population. More than five million rapid antigen tests were conducted in a pilot, a first round of national testing, and in a second round targeted to high prevalence counties. More than 50,000 participants tested positive. Combining the pilot results with the ones from the two rounds of testing, each round of mass testing was estimated to have reduced observed infection prevalence by 56%, say Martin Pavelka et al. The 41 counties with two rounds of testing likely reduced infection prevalence by 81% within two weeks. Further modelling by Pavelka et al. suggests the observed reductions could not be explained solely by infection control measures but required the additional impact of isolation of those who tested positive. "The observational nature of this study made it difficult to separate the effects of the mass testing campaigns from the other non-pharmaceutical interventions introduced over the same period," say the authors. "Nevertheless, a greater than 50% decline in infection prevalence within one week is striking, particularly while primary schools and workplaces were mostly open." For comparison, a month-long lockdown in November in the United Kingdom led to just a 30% decrease in prevalence.

Credit: 
American Association for the Advancement of Science (AAAS)

Pfizer vaccine less effective against S. African variant, Ben-Gurion U. study finds

BEER-SHEVA, Israel, March 23, 2021 - Ben-Gurion University of the Negev (BGU) researchers have found that the Pfizer Coronavirus vaccine is moderately less effective against the South African variant, but still neutralizes the British variant and the original SARS-CoV-2 strain.

Their research was just published in the prestigious journal Cell Host and Microbe.

"Our findings show that future variants could necessitate a modified vaccine as the virus mutates to increase its infectivity," says principal investigator Dr. Ran Taube of the Shraga Segal Department of Microbiology, Immunology and Genetics in the Faculty of Health Sciences.

The BGU scientists evaluated the vaccine effectiveness against the original viral strain, the British and the South African variants, as well as strains that harbor combined changes in the viral spike.

Dr. Taube and his team also evaluated neutralizing antibody levels following administration of one and two vaccine doses. They found that vaccination provided optimal protection when compared with the levels observed in recovered patients. The researchers are continuing to test other circulating variants as they emerge, consisting of mutations that could possibly compromise the vaccine.

Credit: 
American Associates, Ben-Gurion University of the Negev

New anti-cancer therapy: Converting glioma cells into neurons

image: Glioma cell-converted neurons. Red cells are glioma cells; green cells are converted new neurons.

Image: 
Jinan University

Glioma is a fatal neurological disorder that has limited interventional treatment, despite extensive research over the past several decades. A research team led by Dr. Gong Chen, a former professor at Penn State University and now leading a brain repair center at Jinan University in China, has developed a novel gene therapy to reprogram glioma cells into functional neurons, shedding new light on glioma treatment. The work has been published in Cancer Biology & Medicine on March 22, 2021

Glioma is a common malignant cancer growing in the central nervous system. For patients with a type of severe glioma called glioblastoma, the median survival time is typically less than 15 months. Surgical removal followed with chemotherapy and/or radiation therapy are the major ways of treatment but their effectiveness is limited. Several clinical trials are ongoing using engineered immune cells to target primary or recurrent glioma, but still meet with serious hurdles to be solved.

Glioma is caused by aggressive proliferation of glial cells. Chen's team has previously published a series of work demonstrating that brain internal glial cells can be directly converted into functional neurons after overexpressing neural transcription factors such as NeuroD1 and Dlx2. In this work, the team further extended their research from glial cells to glioma cells and discovered that neural transcription factors can also efficiently convert glioma cells into neurons.

"Our cell conversion therapy for glioma is quite unique and distinct from conventional cancer therapies that typically aim at killing cancer cells," commented by Prof. Chen. "One major side effect caused by killing cancer cells is the inevitable collateral damage on normal cells. In contrast, when we use gene therapy technology to convert glioma cells into neurons, normal cells are minimally affected", Prof. Chen explained why they developed this new technology.

"Another important advantage of our gene therapy approach is that after overexpressing neural transcription factor(s) such as NeuroD1 or other transcription factors into glioma cells, the glioma cells stop proliferation immediately before being converted into neurons. Therefore, this transcription factor-based gene therapy may provide a new strategy to prolong the time window of treatment by arresting rapid proliferation of malignant glioma cells," added Dr. Xin Wang, the first author of this work.

While excited about their new findings, Prof. Chen and colleagues also acknowledge that this new technology of treating glioma with transcription factor-based gene therapy is still in its infant stage. Many technical issues still need to be considered, such as developing a safe viral delivery system, targeting glioma cells in a specific way, and potential side effects induced by neural transcription factors. They also plan to combine their cell conversion therapy together with other interventions to achieve synergistic effects to treat glioma.

Credit: 
Guangdong-Hongkong-Macau Institute of CNS Regeneration, Jinan University

Breakthrough in developing new diagnostic procedure for pulmonary aspergillosis

Scientists have developed a pioneering new procedure that will help diagnose a potentially lethal fungal lung disease with greater speed and accuracy, and with less distress to the patient.

A team of international scientists, including Professor Chris Thornton from the University of Exeter, has created a new diagnostic procedure for pulmonary aspergillosis.

Aspergillus is a common mold readily found worldwide in a variety of environments, such as soil and decaying plant material, and can easily be inhaled as air-borne spores in everyday life.

While people with healthy immune systems are able to combat these spores when inhaled, those who have a weakened immune system from illness or medications have fewer infection-fighting cells. This allows Aspergillus to take hold, invading the lungs and, in the most serious cases, other parts of the body.

For COVID-19 patients admitted in intensive care units in particular, the infection has become a significant problem - an estimated 30 percent of them develop COVID-19-Associated Pulmonary Aspergillosis.

The diagnosis of the infection is extremely difficult, and current diagnostic procedures are unpleasant for the already weakened patients. Medical professionals rely on highly invasive techniques such as lung biopsies or broncho-alveolar lavages - where fluid is injected directly into the lungs through the nose or mouth.

Now, the team of researchers have conducted a study, using a mouse model of infection, and utilizing a patent-pending Aspergillus-specific monoclonal antibody, JF5, developed by ground-breaking University of Exeter spin-out company, ISCA Diagnostics.

The research shows that the humanised JF5 antibody can specifically and rapidly recognize the infection in the lungs of infected animals without the need for the invasive procedures.

Using a radiotracer injected only intravenously, advanced molecular imaging techniques developed at the University of Tübingen were able to provide a rapid and specific diagnosis of the disease while allowing for precise monitoring of therapy.

The imaging results were then be complemented by 3D microscopy performed at the University of Duisburg-Essen, which underlined the accuracy of the developed imaging method with a precise (quantitative) evaluation of the infection.

This innovative dual approach proved that all sites of infection could be accurately uncovered, a crucial step to not only provide an estimate of the severity of the infection, but also as a first step in monitoring the success of its treatment.

The researchers demonstrated the potential of therapy monitoring using molecular imaging during administration of the front-line antifungal drug Voriconazole.

Professor Thornton, an expert in Fungal Immunology at the University of Exeter and co-author of the published work said: "This highly innovative and ground-breaking diagnostic technology is a step-change in the way we diagnose this devastating disease of immunocompromised patients, eliminating our current reliance on unpleasant invasive procedures."

"We strongly expect," says Dr. Nicolas Beziere of the Department of Preclinical Imaging and Radiopharmacy at Tübingen University Hospital and senior author of the study, "that the performance of the newly developed radiotracer will be similar in humans and hope that future clinical trials will show a highly positive impact on survivability with a far lower risk and higher comfort for the patient."

Credit: 
University of Exeter